A detailed history of Woodline Partners LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Woodline Partners LP holds 1,047,553 shares of TEVA stock, worth $18.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,047,553
Previous 1,047,553 -0.0%
Holding current value
$18.7 Million
Previous $14.8 Million 15.17%
% of portfolio
0.17%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $8.51 Million - $11.1 Million
1,047,553 New
1,047,553 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $15.1 Million - $21.2 Million
2,040,175 New
2,040,175 $15.3 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.